CSPC Pharmaceutical Group (HKSE:01093) Total Long-Term Assets : HK$24,024 Mil (As of Dec. 2024)

View and export this data going back to 1994. Start your Free Trial

What is CSPC Pharmaceutical Group Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. CSPC Pharmaceutical Group's Total Long-Term Assets for the quarter that ended in Dec. 2024 was HK$24,024 Mil.

CSPC Pharmaceutical Group Total Long-Term Assets Historical Data

The historical data trend for CSPC Pharmaceutical Group's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSPC Pharmaceutical Group Total Long-Term Assets Chart

CSPC Pharmaceutical Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Long-Term Assets

Get a 7-Day Free Trial

16,772.50

17,638.54

19,891.61

21,369.40

24,023.53

CSPC Pharmaceutical Group Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Long-Term Assets	Get a 7-Day Free Trial															-	23,070.43	-	24,023.53	-

CSPC Pharmaceutical Group Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

CSPC Pharmaceutical Group Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (HKSE:01093) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

CSPCY:USA CHJTF:USA CVGU:Germany CVG:Germany CVG:Germany

Address

No.896 Zhongshandong Street, Gaoxin District, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C and antibiotics.

Executives

Ubs Group Ag	2201 Interest of corporation controlled by you
Cai Dong Chen	2201 Interest of corporation controlled by you
True Ally Holdings Limited	2201 Interest of corporation controlled by you
Citigroup Inc.	2502 Approved lending agent
Blackrock, Inc.	2201 Interest of corporation controlled by you
Gong Cheng Guo Ji You Xian Gong Si	2101 Beneficial owner
Ding Da Ji Tuan You Xian Gong Si	2101 Beneficial owner

CSPC Pharmaceutical Group Headlines

No Headlines